Fortunately, we already have a head start on the first phase of vaccine development: research. nyti.ms/3d3AhR4
“The manufacturing task is insurmountable,” said Vijay Samant, the former head of vaccine manufacturing at Merck. “I get sleepless nights thinking about it.” nyti.ms/3d3AhR4
Read on. nyti.ms/3d3AhR4